Literature DB >> 33489675

Improved efficiency of genome editing by constitutive expression of Cas9 endonuclease in genetically-modified mice.

Bita Ghassemi1, Monire Jamalkhah2, Gelareh Shokri3, Mousa Kehtari4, Masoud Soleimani5, Mehdi Shamsara6, Jafar Kiani7,8.   

Abstract

Despite its convenience and precision, CRISPR-based gene editing approaches still suffer from off-target effects and low efficiencies, which are partially rooted in Cas9, the nuclease component of the CRISPR/Cas9 system. In this study, we showed how mouse genome editing efficiency can be improved by constitutive and inheritable expression of Cas9 nuclease. For this goal, a transgenic mouse line expressing the Cas9 protein (Cas9-mouse) was generated. For in vitro assessment of gene editing efficiency, the Cas9-mice were crossed with the EGFP-mice to obtain mouse embryonic fibroblasts (MEF) expressing both EGFP and Cas9 (MEFCas9-EGFP). Transfection of these cells with in vitro transcribed (IVT) EGFP sgRNA or phU6-EGFPsgRNA plasmid led to robust decrease of Mean Fluorescent Intensity (MFI) to 8500 ± 1025 a.u. and 13,200 ± 1006 a.u. respectively. However, in the control group, in which the MEFEGFP cells were transfected with a pX330-EGFPsgRNA plasmid, the measured MFI was 16,800 ± 2254 a.u. For in vivo assessment, the Cas9-zygotes at two pronuclei stage (2PN) were microinjected with a phU6-HhexsgRNA vector and the gene mutation efficiency was compared with the wild-type (WT) zygotes microinjected with a pX330-HhexsgRNA plasmid. The analysis of born mice showed that while the injection of Cas9-zygotes resulted in 43.75% Hhex gene mutated mice, it was just 15.79% for the WT zygotes. In conclusion, the inheritable and constitutive expression of Cas9 in mice provides an efficient platform for gene editing, which can facilitate the production of genetically-modified cells and animals. © King Abdulaziz City for Science and Technology 2021.

Entities:  

Keywords:  CRISPR-Cas9; Gene knock-out; Genetically-modified cells and mice; Microinjection

Year:  2021        PMID: 33489675      PMCID: PMC7801580          DOI: 10.1007/s13205-020-02580-z

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  19 in total

1.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

2.  Protection against telomeric position effects by the chicken cHS4 beta-globin insulator.

Authors:  Héctor Rincón-Arano; Mayra Furlan-Magaril; Félix Recillas-Targa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

Review 3.  Animal transgenesis: an overview.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Brain Struct Funct       Date:  2009-11-25       Impact factor: 3.270

4.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

5.  Pipeline for the generation of gene knockout mice using dual sgRNA CRISPR/Cas9-mediated gene editing.

Authors:  Bita Ghassemi; Mehdi Shamsara; Masoud Soleimani; Jafar Kiani; Minoo Rassoulzadegan
Journal:  Anal Biochem       Date:  2018-12-26       Impact factor: 3.365

6.  Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.

Authors:  Hao Yin; Wen Xue; Sidi Chen; Roman L Bogorad; Eric Benedetti; Markus Grompe; Victor Koteliansky; Phillip A Sharp; Tyler Jacks; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2014-03-30       Impact factor: 54.908

7.  Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA.

Authors:  Katalin Karikó; Hiromi Muramatsu; János Ludwig; Drew Weissman
Journal:  Nucleic Acids Res       Date:  2011-09-02       Impact factor: 16.971

8.  CRISPR-mediated direct mutation of cancer genes in the mouse liver.

Authors:  Wen Xue; Sidi Chen; Hao Yin; Tuomas Tammela; Thales Papagiannakopoulos; Nikhil S Joshi; Wenxin Cai; Gillian Yang; Roderick Bronson; Denise G Crowley; Feng Zhang; Daniel G Anderson; Phillip A Sharp; Tyler Jacks
Journal:  Nature       Date:  2014-08-06       Impact factor: 49.962

9.  Validation of microinjection methods for generating knockout mice by CRISPR/Cas-mediated genome engineering.

Authors:  Takuro Horii; Yuji Arai; Miho Yamazaki; Sumiyo Morita; Mika Kimura; Masahiro Itoh; Yumiko Abe; Izuho Hatada
Journal:  Sci Rep       Date:  2014-03-28       Impact factor: 4.379

10.  Generation of an Oocyte-Specific Cas9 Transgenic Mouse for Genome Editing.

Authors:  Linlin Zhang; Jiankui Zhou; Jinxiong Han; Bian Hu; Ningning Hou; Yun Shi; Xingxu Huang; Xin Lou
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.